ARTICLE | Company News
Tanox Biosystems autoimmune/inflammation news
March 25, 1996 8:00 AM UTC
Tanox began building a $10 million, 13,900-square foot pilot manufacturing plant to supply product for Phase III trials and commercialization of its CGP 51901 anti-IgE monoclonal antibody for allergy ...